RadNet, Inc. (RDNT) Shares Bought by National Planning Corp

National Planning Corp boosted its position in shares of RadNet, Inc. (NASDAQ:RDNT) by 9.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 16,796 shares of the medical research company’s stock after buying an additional 1,500 shares during the period. National Planning Corp’s holdings in RadNet were worth $132,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. TFS Capital LLC boosted its position in shares of RadNet by 238.0% in the first quarter. TFS Capital LLC now owns 121,948 shares of the medical research company’s stock worth $719,000 after buying an additional 85,872 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of RadNet by 8.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,375,696 shares of the medical research company’s stock worth $8,873,000 after buying an additional 103,885 shares in the last quarter. Cadence Capital Management LLC boosted its position in shares of RadNet by 32.5% in the first quarter. Cadence Capital Management LLC now owns 171,565 shares of the medical research company’s stock worth $1,012,000 after buying an additional 42,107 shares in the last quarter. State Street Corp boosted its position in shares of RadNet by 9.1% in the fourth quarter. State Street Corp now owns 614,416 shares of the medical research company’s stock worth $3,962,000 after buying an additional 51,027 shares in the last quarter. Finally, American International Group Inc. boosted its position in shares of RadNet by 7.0% in the first quarter. American International Group Inc. now owns 22,857 shares of the medical research company’s stock worth $135,000 after buying an additional 1,500 shares in the last quarter. Institutional investors and hedge funds own 46.00% of the company’s stock.

Shares of RadNet, Inc. (NASDAQ RDNT) opened at 8.25 on Friday. The firm has a market cap of $389.94 million, a price-to-earnings ratio of 43.42 and a beta of 1.01. The company’s 50 day moving average price is $7.80 and its 200-day moving average price is $6.74. RadNet, Inc. has a 1-year low of $5.25 and a 1-year high of $8.70.

RadNet (NASDAQ:RDNT) last posted its quarterly earnings data on Tuesday, August 8th. The medical research company reported $0.11 EPS for the quarter, topping the Zacks’ consensus estimate of $0.04 by $0.07. The company had revenue of $230 million for the quarter, compared to the consensus estimate of $230.32 million. RadNet had a return on equity of 19.98% and a net margin of 1.04%. The company’s quarterly revenue was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.09 EPS. Equities analysts expect that RadNet, Inc. will post $0.29 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://www.com-unik.info/2017/08/18/radnet-inc-rdnt-shares-bought-by-national-planning-corp.html.

Separately, Zacks Investment Research upgraded RadNet from a “sell” rating to a “hold” rating in a research report on Wednesday, May 17th.

In other news, insider Norman R. Hames sold 10,000 shares of the business’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $7.38, for a total transaction of $73,800.00. Following the sale, the insider now directly owns 457,131 shares of the company’s stock, valued at $3,373,626.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael N. Murdock sold 10,400 shares of the business’s stock in a transaction on Monday, May 22nd. The stock was sold at an average price of $7.61, for a total value of $79,144.00. Following the sale, the insider now directly owns 220,428 shares in the company, valued at $1,677,457.08. The disclosure for this sale can be found here. Insiders have sold 148,870 shares of company stock worth $1,124,462 over the last ninety days. 9.36% of the stock is owned by insiders.

RadNet Company Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

What are top analysts saying about RadNet Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for RadNet Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit